MTT5
Product Specifications
Target
TLR
Related Pathways
Immunology/Inflammation
Bioactivity
MTT5, a toll-like receptor 7 (TLR7) agonist, can be conjugated with Deruxtecan to exert antitumor activity in HER2-positive solid tumors through tumor cell killing and immune activation.
Molecular Formula
C22H27N7O4
Molecular Weight
453.49
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog